Literature DB >> 16671893

NF-Y and Sp1/Sp3 are involved in the transcriptional regulation of the peptidylarginine deiminase type III gene (PADI3) in human keratinocytes.

Sijun Dong1, Takuya Kanno, Ayako Yamaki, Toshio Kojima, Masakazu Shiraiwa, Akira Kawada, Marie-Claire Méchin, Stéphane Chavanas, Guy Serre, Michel Simon, Hidenari Takahara.   

Abstract

Human peptidylarginine deiminase type III gene (PADI3) encodes a crucial post-translational modification enzyme that converts protein-bound arginine residues into citrulline residues. Its expression is restricted to a few cell types, including keratinocytes in the granular layer of the epidermis and in the inner root sheath of hair follicles. In these cells, the enzyme is involved in terminal processing of intermediate filament-binding proteins such as filaggrin and trichohyalin. To study the molecular mechanisms that control the expression of PADI3 in human keratinocytes at the transcriptional level, we characterized its promoter region using human keratinocytes transfected with variously deleted fragments of the 5'-upstream region of PADI3 coupled to the luciferase gene. We found that as few as 129 bp upstream from the transcription initiation site were sufficient to direct transcription of the reporter gene. Electrophoretic mobility-shift and chromatin immunoprecipitation assays revealed that NF-Y (nuclear factor Y) and Sp1/Sp3 (specificity protein 1/3) bind to this region in vitro and in vivo. Moreover, mutation of the Sp1- or NF-Y-binding motif markedly reduced PADI3 promoter activity. Furthermore, Sp1 or NF-YA (NF-Y subunit) small interfering RNAs effectively diminished PADI3 expression in keratinocytes cultured in both low- and high-calcium medium. These data indicate that PADI3 expression is driven by Sp1/Sp3 and NF-Y binding to the promoter region.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16671893      PMCID: PMC1533312          DOI: 10.1042/BJ20051939

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  41 in total

1.  Interaction between the two ubiquitously expressed transcription factors NF-Y and Sp1.

Authors:  K Roder; S S Wolf; K J Larkin; M Schweizer
Journal:  Gene       Date:  1999-06-24       Impact factor: 3.688

2.  Sterol regulation of human fatty acid synthase promoter I requires nuclear factor-Y- and Sp-1-binding sites.

Authors:  S Xiong; S S Chirala; S J Wakil
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-11       Impact factor: 11.205

3.  Transcriptional activation of the MDR1 gene by UV irradiation. Role of NF-Y and Sp1.

Authors:  Z Hu; S Jin; K W Scotto
Journal:  J Biol Chem       Date:  2000-01-28       Impact factor: 5.157

4.  Cholesterol biosynthesis from lanosterol. A concerted role for Sp1 and NF-Y-binding sites for sterol-mediated regulation of rat 7-dehydrocholesterol reductase gene expression.

Authors:  J H Kim; J N Lee; Y K Paik
Journal:  J Biol Chem       Date:  2001-03-13       Impact factor: 5.157

5.  Sp family members and nuclear factor-Y cooperatively stimulate transcription from the rat pyruvate kinase M gene distal promoter region via their direct interactions.

Authors:  K Yamada; T Tanaka; K Miyamoto; T Noguchi
Journal:  J Biol Chem       Date:  2000-06-16       Impact factor: 5.157

6.  Sp1 and NF-Y synergistically mediate the effect of vitamin D(3) in the p27(Kip1) gene promoter that lacks vitamin D response elements.

Authors:  T Inoue; J Kamiyama; T Sakai
Journal:  J Biol Chem       Date:  1999-11-05       Impact factor: 5.157

7.  Isolation and characterization of the human stearoyl-CoA desaturase gene promoter: requirement of a conserved CCAAT cis-element.

Authors:  L Zhang; L Ge; T Tran; K Stenn; S M Prouty
Journal:  Biochem J       Date:  2001-07-01       Impact factor: 3.857

8.  Decreased deiminated keratin K1 in psoriatic hyperproliferative epidermis.

Authors:  A Ishida-Yamamoto; T Senshu; H Takahashi; K Akiyama; K Nomura; H Iizuka
Journal:  J Invest Dermatol       Date:  2000-04       Impact factor: 8.551

9.  Human peptidylarginine deiminase type III: molecular cloning and nucleotide sequence of the cDNA, properties of the recombinant enzyme, and immunohistochemical localization in human skin.

Authors:  T Kanno; A Kawada; J Yamanouchi; C Yosida-Noro; A Yoshiki; M Shiraiwa; M Kusakabe; M Manabe; T Tezuka; H Takahara
Journal:  J Invest Dermatol       Date:  2000-11       Impact factor: 8.551

Review 10.  The molecular biology of the CCAAT-binding factor NF-Y.

Authors:  R Mantovani
Journal:  Gene       Date:  1999-10-18       Impact factor: 3.688

View more
  10 in total

1.  Deimination is regulated at multiple levels including auto-deimination of peptidylarginine deiminases.

Authors:  Marie-Claire Méchin; Fanny Coudane; Véronique Adoue; Jacques Arnaud; Hélène Duplan; Marie Charveron; Anne-Marie Schmitt; Hidenari Takahara; Guy Serre; Michel Simon
Journal:  Cell Mol Life Sci       Date:  2010-01-29       Impact factor: 9.261

2.  Bleomycin hydrolase is regulated biphasically in a differentiation- and cytokine-dependent manner: relevance to atopic dermatitis.

Authors:  Yayoi Kamata; Mami Yamamoto; Fumitaka Kawakami; Ryoji Tsuboi; Atsushi Takeda; Kazuhiko Ishihara; Toshihiko Hibino
Journal:  J Biol Chem       Date:  2010-12-29       Impact factor: 5.157

3.  Structural characterization of human peptidyl-arginine deiminase type III by X-ray crystallography.

Authors:  Othman Rechiche; T Verne Lee; J Shaun Lott
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2021-09-21       Impact factor: 1.072

4.  Modulation of calcium-induced cell death in human neural stem cells by the novel peptidylarginine deiminase-AIF pathway.

Authors:  Kin Pong U; Venkataraman Subramanian; Antony P Nicholas; Paul R Thompson; Patrizia Ferretti
Journal:  Biochim Biophys Acta       Date:  2014-03-05

5.  Transcriptome analysis of psoriasis in a large case-control sample: RNA-seq provides insights into disease mechanisms.

Authors:  Bingshan Li; Lam C Tsoi; William R Swindell; Johann E Gudjonsson; Trilokraj Tejasvi; Andrew Johnston; Jun Ding; Philip E Stuart; Xianying Xing; James J Kochkodan; John J Voorhees; Hyun M Kang; Rajan P Nair; Goncalo R Abecasis; James T Elder
Journal:  J Invest Dermatol       Date:  2014-01-17       Impact factor: 8.551

6.  Marine biogenics in sea spray aerosols interact with the mTOR signaling pathway.

Authors:  Jana Asselman; Emmanuel Van Acker; Maarten De Rijcke; Laurentijn Tilleman; Filip Van Nieuwerburgh; Jan Mees; Karel A C De Schamphelaere; Colin R Janssen
Journal:  Sci Rep       Date:  2019-01-24       Impact factor: 4.379

7.  Human Enzyme PADI4 Binds to the Nuclear Carrier Importin α3.

Authors:  José L Neira; Bruno Rizzuti; Olga Abián; Salomé Araujo-Abad; Adrián Velázquez-Campoy; Camino de Juan Romero
Journal:  Cells       Date:  2022-07-11       Impact factor: 7.666

8.  Long-range enhancer associated with chromatin looping allows AP-1 regulation of the peptidylarginine deiminase 3 gene in differentiated keratinocyte.

Authors:  Stéphane Chavanas; Véronique Adoue; Marie-Claire Méchin; Shibo Ying; Sijun Dong; Hélène Duplan; Marie Charveron; Hidenari Takahara; Guy Serre; Michel Simon
Journal:  PLoS One       Date:  2008-10-16       Impact factor: 3.240

9.  Peptidylarginine Deiminase 3 (PAD3) Is Upregulated by Prolactin Stimulation of CID-9 Cells and Expressed in the Lactating Mouse Mammary Gland.

Authors:  Guangyuan Li; Isaac N Hayward; Brittany R Jenkins; Heather M Rothfuss; Coleman H Young; Marja T Nevalainen; Aaron Muth; Paul R Thompson; Amy M Navratil; Brian D Cherrington
Journal:  PLoS One       Date:  2016-01-22       Impact factor: 3.240

10.  PADI3 induces cell cycle arrest via the Sirt2/AKT/p21 pathway and acts as a tumor suppressor gene in colon cancer.

Authors:  Xiaotian Chang; Zhengbin Chai; Jiaorui Zou; Hongxing Wang; Yao Wang; Yabing Zheng; Hui Wu; Chunyan Liu
Journal:  Cancer Biol Med       Date:  2019-11       Impact factor: 4.248

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.